Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration. (Q54523252)

30 May 2018

title

Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration. (English)

1 reference

30 May 2018

author name string

Shimiao Wang

1

1 reference

30 May 2018

Xiaohui Li

2

1 reference

30 May 2018

Yingdong Wei

3

1 reference

30 May 2018

Zhilong Xiu

4

1 reference

30 May 2018

Norikazu Nishino

5

1 reference

30 May 2018

publication date

27 November 2013

1 reference

30 May 2018

published in

ChemMedChem

1 reference

30 May 2018

volume

9

1 reference

30 May 2018

issue

3

1 reference

30 May 2018

page(s)

627-637

1 reference

30 May 2018

Regulation of histone deacetylase activities

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

The Language of Histone Crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitors: molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Lysine acetylation targets protein complexes and co-regulates major cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Substrate and functional diversity of lysine acetylation revealed by a proteomics survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitors: overview and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Clonogenic assay of cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Mechanisms of G1 cell cycle arrest and apoptosis in myeloma cells induced by hybrid-compound histone deacetylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Chemical origins of isoform selectivity in histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Molecular design of histone deacetylase inhibitors by aromatic ring shifting in chlamydocin framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Synthesis, evaluation and molecular modeling of cyclic tetrapeptide histone deacetylase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone Deacetylase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

HDAC inhibitors: clinical update and mechanism-based potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

A novel class of small molecule inhibitors of HDAC6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Epigenomics of leukemia: from mechanisms to therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Regulation of the G1 phase of the mammalian cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Ceramide inhibition of MMP-2 expression and human cancer bronchial cell invasiveness involve decreased histone acetylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Matrix metalloproteinases: regulators of the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylase HDAC1/HDAC2-controlled embryonic development and cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Comparative analysis of the role of small G proteins in cell migration and cell death: cytoprotective and promigratory effects of RalA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Specific activity of class II histone deacetylases in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Histone deacetylases and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

The regulation of matrix metalloproteinases and their inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Exploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

Highly Potent and Selective Histone Deacetylase 6 Inhibitors Designed Based on a Small-Molecular Substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

An overview of the cell cycle arrest protein, p21(WAF1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

inferred from DOI database lookup

7 January 2021

based on heuristic

Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201300372

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201300372

1 reference

30 May 2018

1 reference

30 May 2018